Cancer Susceptibility Counseling and Decisions (CASCADE)

NOT ENROLLING
Protocol # :
22-110
Conditions
BRCA1 Mutation
BRCA2 Mutation
Phase
II
Disease Sites
Healthy volunteer
Transplanted organ and tissue status, unspecified
Disease not specified
Neuroendocrine/Carcinoid
Gastroesophageal Junction
Gallbladder/Biliary
Other specified personal risk factors, not elsewhere classified
Lip, Oral Cavity and Pharynx
Esophagus
Stomach
Small Intestine
Colon
Rectum
Anus
Liver
Pancreas
Other Digestive Organ
Larynx
Lung
Other Respiratory and Intrathoracic Organs
Bones and Joints
Soft Tissue
Mycosis Fungoides
Other Skin
Breast
Cervix
Corpus Uteri
Ovary
Other Female Genital
Prostate
Other Male Genital
Urinary Bladder
Kidney
Other Urinary
Eye and Orbit
Brain and Nervous System
Thyroid
Other Hematopoietic
Unknown Sites
Ill-Defined Sites
Other Endocrine System
Non-Hodgkin's Lymphoma
Hodgkin's Lymphoma
Multiple Myeloma
Lymphoid Leukemia
Myeloid and Monocytic Leukemia
Leukemia, other
Donors
Kaposi's Sarcoma
Melanoma, Skin
Principal Investigator
Rana, Huma

Trial Description

The primary goal of this research is to test a web-based genetic education intervention
that is designed to educate men and women from hereditary cancer families about the
personal relevance of genetic testing in order to help them male decisions about whether
to pursue genetic testing. We will test this intervention against standard care for men
and women from hereditary cancer families. The web-based educational intervention
includes all of the information typically covered during genetic counseling. As a result,
after completing the education intervention, participants can proceed directly to a brief
telephone call with a genetic counselor followed by testing if they choose. A baseline
survey will be administered prior to randomization and then follow-up surveys will be
administered at 1-month and 6-months post-randomization. Primary outcomes will be
completion of genetic counseling, uptake of genetic testing, genetic test results and
quality of life.

Eligibility Requirements

Inclusion Criteria:

- A first- (sibling, adult offspring) or second-degree (aunt/uncle, niece/nephew if
at-risk parent is deceased) biological relative of an individual with a recently
identified BRCA1 or BRCA2 mutation

Exclusion Criteria:

- Personal diagnosis of metastatic cancer

- Prior genetic testing for hereditary breast/ovarian cancer

- Have one or more children who have tested positive for a BRCA1 or BRCA2 mutation

- Cannot participate in or understand English

- Cannot provide meaningful informed consent

22-110